BIOMAT Database Logo BIOMAT Database Logo

1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation. 2009

Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
Dipartimento di Chimica e Tecnologie del Farmaco, Università La Sapienza, I-00185 Roma, Italy. mariangela.biava@uniroma1.it

During the search of novel antitubercular drugs related to BM 212, new diarylpyrroles were designed and synthesized on the basis of a structure-activity relationship analysis of many pyrroles previously described by us. Among them, 1-(4-fluorophenyl)-2-ethyl-3-(thiomorpholin-4-yl)methyl-5-(4-methylphenyl)-1H-pyrrole (2b) proved to be particularly active, with a minimum inhibitory concentration (MIC, expressed as microg/mL) and a protection index (PI) better than or comparable to those of reference compounds. Also the remaining compounds were very active, although their MIC and PI were in general lower than those of their parent 2-methyl analogues.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
Design, synthesis, and biological evaluation of 1,5-diaryl-1,2,4-triazole derivatives as selective cyclooxygenase-2 inhibitors.
September 2010, Archiv der Pharmazie,
Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
Novel diaryl ether derivatives as InhA inhibitors: Design, synthesis and antimycobacterial activity.
December 2022, Bioorganic chemistry,
Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
Design and synthesis of benzimidazole derivatives as antimycobacterial agents.
September 2022, Journal of biochemical and molecular toxicology,
Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
May 2019, European journal of medicinal chemistry,
Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents.
April 2014, European journal of medicinal chemistry,
Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
Design, synthesis and biological evaluation of 3,5-diaryl isoxazole derivatives as potential anticancer agents.
October 2020, Bioorganic & medicinal chemistry letters,
Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
Synthesis and biological evaluation of 2-aminothiazole derivatives as antimycobacterial and antiplasmodial agents.
January 2014, Bioorganic & medicinal chemistry letters,
Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents.
January 2016, European journal of medicinal chemistry,
Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
New Pyrrole Derivatives as Promising Biological Agents: Design, Synthesis, Characterization, In Silico, and Cytotoxicity Evaluation.
August 2022, International journal of molecular sciences,
Mariangela Biava, and Giulio C Porretta, and Giovanna Poce, and Alessandro De Logu, and Rita Meleddu, and Edda De Rossi, and Fabrizio Manetti, and Maurizio Botta
New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents.
December 2023, RSC medicinal chemistry,
Copied contents to your clipboard!